rs201106410
Variant names:
Variant summary
Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_001492.6(GDF1):c.-873C>T variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00182 in 1,613,398 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0013 ( 0 hom., cov: 31)
Exomes 𝑓: 0.0019 ( 4 hom. )
Consequence
GDF1
NM_001492.6 5_prime_UTR_premature_start_codon_gain
NM_001492.6 5_prime_UTR_premature_start_codon_gain
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.97
Publications
0 publications found
Genes affected
GDF1 (HGNC:4214): (growth differentiation factor 1) This gene encodes a secreted ligand of the TGF-beta (transforming growth factor-beta) superfamily of proteins. Ligands of this family bind various TGF-beta receptors leading to recruitment and activation of SMAD family transcription factors that regulate gene expression. The encoded preproprotein is proteolytically processed to generate each subunit of the disulfide-linked homodimer. Studies in rodents suggest that this protein is involved in the establishment of left-right asymmetry in early embryogenesis and in neural development in later embryogenesis. The encoded protein is translated from a bicistronic mRNA that also encodes ceramide synthase 1. Mutations in this gene are associated with several congenital cardiovascular malformations. [provided by RefSeq, Jul 2016]
CERS1 (HGNC:14253): (ceramide synthase 1) This gene encodes a ceramide synthase enzyme, which catalyzes the synthesis of ceramide, the hydrophobic moiety of sphingolipids. The encoded enzyme synthesizes 18-carbon (C18) ceramide in brain neurons. Elevated expression of this gene may be associated with increased longevity, while decreased expression of this gene may be associated with myoclonus epilepsy with dementia in human patients. This protein is transcribed from a monocistronic mRNA as well as a bicistronic mRNA, which also encodes growth differentiation factor 1. [provided by RefSeq, Jul 2016]
CERS1 Gene-Disease associations (from GenCC):
- progressive myoclonic epilepsy type 8Inheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -16 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BP6
Variant 19-18884227-G-A is Benign according to our data. Variant chr19-18884227-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 475372.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Homozygotes in GnomAdExome4 at 4 AD,AR,Unknown gene
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| GDF1 | NM_001492.6 | c.-873C>T | 5_prime_UTR_premature_start_codon_gain_variant | Exon 3 of 8 | ENST00000247005.8 | NP_001483.3 | ||
| CERS1 | NM_021267.5 | c.450C>T | p.Ala150Ala | synonymous_variant | Exon 3 of 8 | ENST00000623882.4 | NP_067090.1 | |
| GDF1 | NM_001492.6 | c.-873C>T | 5_prime_UTR_variant | Exon 3 of 8 | ENST00000247005.8 | NP_001483.3 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| GDF1 | ENST00000247005.8 | c.-873C>T | 5_prime_UTR_premature_start_codon_gain_variant | Exon 3 of 8 | 1 | NM_001492.6 | ENSP00000247005.5 | |||
| CERS1 | ENST00000623882.4 | c.450C>T | p.Ala150Ala | synonymous_variant | Exon 3 of 8 | 1 | NM_021267.5 | ENSP00000485308.1 | ||
| GDF1 | ENST00000247005.8 | c.-873C>T | 5_prime_UTR_variant | Exon 3 of 8 | 1 | NM_001492.6 | ENSP00000247005.5 |
Frequencies
GnomAD3 genomes AF: 0.00130 AC: 198AN: 151998Hom.: 0 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
198
AN:
151998
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00117 AC: 287AN: 245376 AF XY: 0.00112 show subpopulations
GnomAD2 exomes
AF:
AC:
287
AN:
245376
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00188 AC: 2740AN: 1461282Hom.: 4 Cov.: 31 AF XY: 0.00180 AC XY: 1308AN XY: 726920 show subpopulations
GnomAD4 exome
AF:
AC:
2740
AN:
1461282
Hom.:
Cov.:
31
AF XY:
AC XY:
1308
AN XY:
726920
show subpopulations
African (AFR)
AF:
AC:
15
AN:
33478
American (AMR)
AF:
AC:
111
AN:
44708
Ashkenazi Jewish (ASJ)
AF:
AC:
1
AN:
26128
East Asian (EAS)
AF:
AC:
0
AN:
39690
South Asian (SAS)
AF:
AC:
44
AN:
86212
European-Finnish (FIN)
AF:
AC:
18
AN:
53174
Middle Eastern (MID)
AF:
AC:
2
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
2469
AN:
1111770
Other (OTH)
AF:
AC:
80
AN:
60354
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
152
303
455
606
758
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
104
208
312
416
520
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00131 AC: 199AN: 152116Hom.: 0 Cov.: 31 AF XY: 0.00128 AC XY: 95AN XY: 74378 show subpopulations
GnomAD4 genome
AF:
AC:
199
AN:
152116
Hom.:
Cov.:
31
AF XY:
AC XY:
95
AN XY:
74378
show subpopulations
African (AFR)
AF:
AC:
16
AN:
41498
American (AMR)
AF:
AC:
41
AN:
15250
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3472
East Asian (EAS)
AF:
AC:
0
AN:
5168
South Asian (SAS)
AF:
AC:
4
AN:
4814
European-Finnish (FIN)
AF:
AC:
5
AN:
10588
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
128
AN:
68010
Other (OTH)
AF:
AC:
5
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
9
19
28
38
47
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:1
Jul 01, 2022
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
CERS1: BP4, BP7 -
Progressive myoclonic epilepsy type 8 Benign:1
Jan 06, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.